Luo, D., Yu, Y., Wang, Q., Peng, T., Li, C., Zhang, W., & Huang, J. The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: A phase 3 randomized controlled trials based meta-analysis. BMC.
Chicago Style (17th ed.) CitationLuo, Deping, Ying Yu, Qi Wang, Tao Peng, Chan Li, Wenxiong Zhang, and Jing Huang. The Benefit and Risk of Addition of PD-1/PD-L1 Inhibitors to Chemotherapy for Advanced Cervical Cancer: A Phase 3 Randomized Controlled Trials Based Meta-analysis. BMC.
MLA (9th ed.) CitationLuo, Deping, et al. The Benefit and Risk of Addition of PD-1/PD-L1 Inhibitors to Chemotherapy for Advanced Cervical Cancer: A Phase 3 Randomized Controlled Trials Based Meta-analysis. BMC.
Warning: These citations may not always be 100% accurate.